Overview


According to FutureWise analysis the market for dupuytren's contracture is expected to register a CAGR of 5.10% from 2023-2031.

Dupuytren’s contracture is a condition that makes it difficult for fingers to move due to the formation of tissue knots underneath the skin. If the condition gets worse, the fingers may become permanently bent in a flex position. Most commonly, the fingers are bent down towards the palm. While it is not painful, the way it bends the fingers makes it uncomfortable. It affects the middle and little fingers. Most people who are over fifty experience this condition. Although the cause is unknown, this condition can be linked to alcoholism and thyroid diseases, diabetes, and smoking. Although the risk is low at the start of the condition the severity can increase if the situation becomes more serious. If the proximal intraphalangeal joint contracture reaches twenty degrees, it is time for surgery. The most serious cases may require steroid therapy or physiotherapy. The Market is one of today's most important industries. Dupuytren's Contracture Market Share displays details of the market and competitors. You will find many details such as company overview, revenue, finance, future and investment opportunities, presence of the company in global medium and production facilities, trials and approvals that enhance the Dupuytren’s Contracture Market Value.

Dupuytren's Disease is a hand malformation that can develop over time. This illness can affect the layer of tissue underneath your palm. In severe cases, fingers can become bent and flexed permanently. Dupuytren contracture most often affects the ring and little fingers. Dupuytren’s contracture can also be caused by smoking, thyroid diseases, liver disease, and diabetes. Past hand injuries, epilepsy, alcoholism, tobacco use, thyroid disorders, liver disease, and diabetes are all possible risk factors. Dupuytren’s contracture, familial palmar fibromatosis, or contraction of the palmar fascia are other names for this condition.

The market's growth rate will be boosted by the rising prevalence of Dupuytren’s Disease. A significant factor that will influence the market growth is the growing healthcare spending. Additionally, the Dupuytren’s disease market will grow due to the advancements in medical technology, increasing public awareness of the disease, and increased government funding. Other factors, such as increasing diabetes rates and an aging population, will have a positive impact on the Dupuytren’s market growth. Dupuytren’s disease market will expand because of the high consumption of alcohol, smoking, and other tobacco products. Market growth will be driven by rising risk factors, increased disposable income, and growing screening. Surgery may be required for people suffering from severe symptoms. Surgery often provides a quicker and more lasting release than the use of needles or enzymes. Recovery can take longer. In severe cases, surgeons may need to remove all tissue affected by Dupuytren contracture. In these cases, a skin transplant is required to cover the open wound. This procedure is the most complicated and requires the longest recovery. Dupuytren Contracture treatment may only provide temporary relief. The contraction of the fingers can often return with time.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Dupuytren's Contracture Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Dupuytren's Contracture Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Bristol-Meyers Squibb
  • Fresenius Kabi AG
  • Merck
  • Pfizer Inc.
  • West-Ward Pharmaceuticals
  • Spear Pharmaceuticals
  • Actiza Pharmaceutical
  • Nantong Jinghua Pharmaceutical Co Ltd.
  • Endo International PLC

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Type

  • Type I
  • Type II
  • Type III

By Diagnosis

  • Physical Examination
  • X-ray
  • Others

By End User

  • Hospitals
  • Clinics
  • Academic and research
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Dupuytren's Contracture Market By Type, By Diagnosis, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.  Dupuytren's Contracture Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Dupuytren's Contracture Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Dupuytren's Contracture Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.  Dupuytren's Contracture Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Type I
        2. Type II
        3. Type III

  • 8.   Dupuytren's Contracture Market, By Diagnosis Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Physical Examination
        2. X-ray
        3. Others

  • 9.   Dupuytren's Contracture Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Clinics
        3. Academic and research
        4. Others

  • 10.   North America Dupuytren's Contracture Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Dupuytren's Contracture Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Dupuytren's Contracture Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Dupuytren's Contracture Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Bristol-Meyers Squibb
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Fresenius Kabi AG
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Merck
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Pfizer Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. West-Ward Pharmaceuticals
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Spear Pharmaceuticals
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Actiza Pharmaceutical
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Nantong Jinghua Pharmaceutical Co Ltd.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Endo International PLC
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients